Fusion protein technologies for biopharmaceuticals : applications and challenges /

The state of the art in biopharmaceutical FUSION PROTEIN DESIGN Fusion proteins belong to the most lucrative biotech drugs-with Enbrel® being one of the best-selling biologics worldwide. Enbrel® represents a milestone of modern therapies just as Humulin®, the first therapeutic recombinant protein fo...

Full description

Bibliographic Details
Other Authors: Schmidt, Stefan R.
Format: eBook
Language:English
Published: Hoboken, New Jersey : John Wiley & Sons, [2013]
Subjects:
Online Access:Full Text via HEAL-Link

Similar Items